颅内肿瘤重复开颅手术风险是否增加:两项前瞻性机构注册研究的并发症与结局汇总分析
基于两项前瞻性机构注册数据的回顾性观察性两中心研究,纳入连续显微手术肿瘤切除患者,比较重复手术与初次手术的3个月发病率、死亡率和并发症。结果显示重复手术不增加发病率风险,死亡率和并发症发生率及严重程度与初次手术相当。
要点
- 463/2403(19.3%)为重复手术,3个月发病率为12.1%(n=290)。
- 重复手术与初次手术的3个月发病率无显著差异(OR 0.98,95%CI 0.72-1.34,p=0.889)。
- 死亡率和并发症发生率及严重程度在初次与重复手术间相当。
核心结论
- 颅内肿瘤重复手术不增加发病率风险,死亡率和并发症发生率及严重程度与初次手术相当。
- 该信息对患者咨询和知情同意过程有价值。
研究设计与样本
- 回顾性观察性两中心研究,数据来自独立的前瞻性机构注册,纳入连续接受显微手术肿瘤切除的患者。
- 共2403例手术,其中463例(19.3%)为重复手术。
- 主要终点为3个月(M3)发病率,定义为卡氏功能量表(KPS)显著下降;次要终点为死亡率、并发症发生率和严重程度(Clavien-Dindo分级,CDG)。
主要发现
- 3个月发病率发生于290例患者(12.1%)。
- 单变量分析中,重复手术患者发生发病率的可能性为初次手术患者的98%(OR 0.98,95%CI 0.72-1.34,p=0.889)。
- 多变量分析校正年龄、性别、肿瘤大小、组织学和后颅窝位置后,关系稳定(aOR 1.25,95%CI 0.90-1.73,p=0.186)。
- 出院时死亡10例(0.4%),3个月时死亡95例(4.0%),组间无差异。
- 至少发生一种并发症855例,初次与重复手术后的发生率(35.5% vs. 35.9%,p=0.892)和严重程度(CDG;p=0.520)相似。
临床怎么用
- 原文结论指出该信息对患者咨询和知情同意过程有价值。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Deciding whether to re-operate patients with intracranial tumor recurrence or remnant is challenging, as the data on safety of repeated procedures is limited. This study set out to evaluate the risks for morbidity, mortality, and complications after repeated operations, and to compare those to primary operations. METHODS: Retrospective observational two-center study on consecutive patients undergoing microsurgical tumor resection. The data derived from independent, prospective institutional registries. The primary endpoint was morbidity at 3 months (M3), defined as significant decrease on the Karnofsky Performance Scale (KPS). Secondary endpoints were mortality, rate and severity of complications according to the Clavien-Dindo Grade (CDG). RESULTS: 463/2403 (19.3%) were repeated procedures. Morbidity at M3 occurred in n = 290 patients (12.1%). In univariable analysis, patients undergoing repeated surgery were 98% as likely as patients undergoing primary surgery to experience morbidity (OR 0.98, 95% CI 0.72-1.34, p = 0.889). In multivariable analysis adjusted for age, sex, tumor size, histology and posterior fossa location, the relationship remained stable (aOR 1.25, 95% CI 0.90-1.73, p = 0.186). Mortality was n = 10 (0.4%) at discharge and n = 95 (4.0%) at M3, without group differences. At least one complication occurred in n = 855, and the rate (35.5% vs. 35.9%, p = 0.892) and severity (CDG; p = 0.520) was similar after primary and repeated procedures. Results were reproduced in subgroup analyses for meningiomas, gliomas and cerebral metastases. CONCLUSIONS: Repeated surgery for intracranial tumors does not increase the risk of morbidity. Mortality, and both the rate and severity of complications are comparable to primary operations. This information is of value for patient counseling and the informed consent process.
引用
- Zattra CM, Zhang DY, Broggi M, et al. Repeated craniotomies for intracranial tumors: is the risk increased? Pooled analysis of two prospective, institutional registries of complications and outcomes. J Neurooncol. 2018. PMID: 30474767. doi:10.1007/s11060-018-03058-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。